Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
My New York City practice has been a refractive-only practice for more than 25 years, offering the full range of FDA-approved vision correction surgery options, from lasers to IOLs.The rate-limiting ...
Among many presentations during a hot topics session at the American Academy of Ophthalmology 2021 annual meeting, speakers discussed the first FDA approved therapy for thyroid eye disease and the ...
FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...
The FineVision trifocal diffractive IOL has three focal points for far, near and intermediate vision. This study examines the outcome of bilateral implantation of this IOL and provides far, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results